-
Recent Posts
- U.S. Transportation Unemployment Tops U.S. Unemployment
- Toyota Motor Q2 FY 2027 Results – First Growth in Three Years!
- UAW Voters Persuasive in Trump Mid-Term Rout!
- Annals of Marketing – Dodge Returns to NASCAR
- Acura Begins U.S. Sales of NSX Reproduction Parts
- Lexus Recall for Instrument Panel Display Failures
- Audi to Build First American Plant in Georgia
- GM Q3 2026 Net $3.3B. More Share Buybacks Coming
- Toyota Installs Two Hydrogen Fueling Stations in Ontario CA
- WEC Barcelona – Toyota Racing Takes Manufacturers’ Title
- Park Outside! Genesis Recall for Power-Seat Motor Fires
- New UAW International Executive Board Sworn In
- First Look – Porsche Mission S Sports Car Concept Debut
- HondaJet APMG S Upgrade Approved by EASA
- Acura to Debut New SUVs Targeting Detroit Models
Recent Comments
- Governor Gretchen Whitmer on Trump Mis-Administration – Record High Gas Prices Persist
- NHTSA on Steering Loss – Ford Recalls F-Series Trucks
- AAA on AAA – August 20 Gasoline Prices Highest Ever!
- Nissan Motor on Nissan Posts ¥77.9B Profit in Q1 of Japanese Fiscal Year
- Jeff Badman on Ford Motor Recalls 850,000 Vehicles for Sudden Stalling
Archives
Meta
Get intelligent commentary on the automobile business and its economic and social effects. Stay informed with AutoInformed.
Covid – Commerce NIST Grant of $153 million to National Institute for Innovation in Manufacturing Biopharmaceuticals
NIIMBL* will work to increase the shelf life and reduce the amount of refrigeration required for messenger RNA vaccines, boost capabilities for rapid production of antigens used in testing and screening for new variants and develop novel technologies for detecting counterfeit vaccines, among other things. Continue reading →